Country: Canada
Language: English
Source: Health Canada
BETAMETHASONE ACETATE; BETAMETHASONE (BETAMETHASONE 21-DISODIUM PHOSPHATE)
SANDOZ CANADA INCORPORATED
H02AB01
BETAMETHASONE
3MG; 3MG
SUSPENSION
BETAMETHASONE ACETATE 3MG; BETAMETHASONE (BETAMETHASONE 21-DISODIUM PHOSPHATE) 3MG
INTRA-ARTICULAR
1X5ML/10X1ML
Prescription
ADRENALS
Active ingredient group (AIG) number: 0206301001; AHFS:
CANCELLED POST MARKET
2019-08-01
_BETAJECT_ _Page 1 of 14_ PRESCRIBING INFORMATION PR BETAJECT BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE INJECTABLE SUSPENSION USP (6MG/ML) STERILE GLUCOCORTICOID Sandoz Canada Inc. Date of Revision: 145 Jules-Léger May 29, 2018 Boucherville, QC, Canada J4B 7K8 Submission Control No: 214913 _BETAJECT_ _Page 2 of 14_ _2018/05/29 _ PR BETAJECT BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE INJECTABLE SUSPENSION USP (6 MG/ML) THERAPEUTIC CLASSIFICATION Glucocorticoid PHARMACOLOGY Betamethasone sodium phosphate and betamethasone acetate injectable suspension is a combination of soluble and slightly soluble betamethasone esters that provides potent anti- inflammatory, antirheumatic and antiallergic effects in the treatment of corticosteroid-responsive disorders. Prompt therapeutic activity is achieved by betamethasone sodium phosphate, which is absorbed quickly after injection. Sustained activity is provided by betamethasone acetate, which is only slightly soluble and becomes a repository for slow absorption, thereby controlling symptoms over a prolonged period. INDICATIONS AND CLINICAL USE BETAJECT is indicated as follows: IM injection in allergic, dermatologic, rheumatic, and other conditions responsive to systemic corticosteroids, including bursitis; Local injection into the affected tissues in bursitis and associated inflammatory disorders of tendons such as tenosynovitis, and inflammatory disorders of muscle such as fibrosis and myositis Intra-articular and periarticular injection in rheumatoid arthritis and osteoarthritis; Intralesional injection in various dermatologic conditions; and Local injection in certain inflammatory and cystic disorders of the foot. CONTRAINDICATIONS Betaject is contraindicated in patients: who are hypersensitive to any components of this product (see DOSAGE FORMS, COMPOSITION AND PACKAGING). with herpes simplex of the eye with systemic fungal infections. with vaccinia with cerebral malaria in idiopathic thrombocytopen Read the complete document